MedTrace Logo

Effects of LDX on Cognitive Processes and Appetite

NCT04181957 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2020-11-06

No results posted yet for this study

Summary

This study will investigate the effect of lisdexamfetamine dimesylate (LDX) on the mediating factors of reward and cognition on appetite.

Conditions

  • Binge Eating
  • Eating Behavior

Interventions

DRUG

Placebo oral tablet

Participants take one dose of placebo (lactose) tablet.

DRUG

Lisdexamfetamine Dimesylate

Participants take one 50mg tablet of lisdexamfetamine dimesylate once.

Sponsors & Collaborators

  • University of Birmingham

    lead OTHER

Principal Investigators

  • Suzanne Higgs, PhD · University of Birmingham

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-05-01
Primary Completion
2020-03-17
Completion
2020-03-17

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04181957 on ClinicalTrials.gov